552 related articles for article (PubMed ID: 11255332)
21. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
22. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
Usmani N; Stables GI; Telfer NR; Stringer MR
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
[TBL] [Abstract][Full Text] [Related]
23. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
24. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
25. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
Park JY; Kim SK; Cho KH; Kim YC
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
[TBL] [Abstract][Full Text] [Related]
26. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study.
Kacerovská D; Pizinger K; Majer F; Smíd F
Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625
[TBL] [Abstract][Full Text] [Related]
28. 5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer.
Hirata Y; Koga S; Fukui N; Yu A; Koshida S; Kosaka Y; Kurokawa T; Moriwaki S
J Dermatol; 2011 Aug; 38(8):748-54. PubMed ID: 21352331
[TBL] [Abstract][Full Text] [Related]
29. Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging.
Wang I; Andersson-Engels S; Nilsson GE; Wårdell K; Svanberg K
Br J Dermatol; 1997 Feb; 136(2):184-9. PubMed ID: 9068729
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
32. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.
Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW
Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
[TBL] [Abstract][Full Text] [Related]
34. [Photodynamic therapy of nasal basal cell carcinoma].
Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
[TBL] [Abstract][Full Text] [Related]
35. Red light laser photodynamic therapy of Bowen's disease.
Parlette EC
J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
[No Abstract] [Full Text] [Related]
36. Photodynamic therapy in the treatment of extensive Bowen's disease.
López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
[TBL] [Abstract][Full Text] [Related]
37. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
38. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
Cairnduff F; Stringer MR; Hudson EJ; Ash DV; Brown SB
Br J Cancer; 1994 Mar; 69(3):605-8. PubMed ID: 8123497
[TBL] [Abstract][Full Text] [Related]
39. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
40. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa.
Souza CS; Felício LB; Bentley MV; Tedesco AC; Ferreira J; Kurachi C; Bagnato VS
Br J Dermatol; 2005 Sep; 153(3):672-4. PubMed ID: 16120168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
